GO
Loading...

Enter multiple symbols separated by commas

More Drugs, Profits in Pipeline at Pfizer

Pfizer , the world's largest drugmaker, has raised its earnings guidance for the year and promised a number of late stage products out of its pipeline in the coming years.

The company raised its adjusted earnings-per-share forecast to a minimum of $2.05, from an earlier forecast of $2. Without adjustments, the company expects earnings at least $1.68 per share.

The company cited favorable revenue trends and lower costs.

Analysts surveyed by Thomson Financial expect earnings per share of $2.02.

The outlook follows Pfizer's announcement Tuesday it would cut 20 percent from its U.S. sales force, or 2,200 jobs.

Pfizer stuck to targeting average adjusted earnings per share growth in the high single digits in 2007 and 2008, from its $2.05-per-share estimate for 2006.

The company expects its late-stage product pipeline to grow dramatically or perhaps even triple from 2006 to 2009. This would give the company four new products a year starting in 2011. Areas of concentration include cardiovascular, metabolic and endocrine diseases focusing on atherosclerosis, obesity, diabetes, bone and muscle health, and blood clots.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Don't Miss

U.S. Video

  • Hero miles for military members: Real estate magnate's plea

    Chairman of the Fisher House Foundation, Ken Fisher, discusses the Hero Miles program with CNBC's Dina Gusovsky. During Military Appreciation Month, Fisher is asking every traveler to donate 1,000 of their miles to replenish the Hero Miles programs that is in danger of running out.

  • Cramer shuts down this market's haters

    "Mad Money" host Jim Cramer on why this market can't stop, won't stop.

  • From the battlefield to the boardroom

    Your Grateful Nation is dedicated to helping Special Forces veterans enter the corporate world and Knot Standard provides complimentary suits to vets. Mad Money's Jim Cramer spoke with Rob Clapper, Your Grateful executive director; John Ballay, Knot Standard co-founder and president; Tej Gill, retired U.S. Navy Seal; and Darren McB, active duty U.S. Navy Seal.